Hong Kong stocks surge | Charoen Pokphand Group International (03839.HK) rises more than 8% again, Muyuan Group and Charoen Pokphand Group reach strategic cooperation, The company is a manufacturer of aureomycin under Charoen Pokphand Group.

According to the Wisdom Finance and Economics APP, Sinopharm Group International (03839.HK) has risen by more than 8% again, with a cumulative increase of over 570% this year. As of the time of writing, the stock has risen by 8.79% to 10.02 Hong Kong dollars, with a trading volume of 15.47 million Hong Kong dollars.